Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Clinical Pharmacology and Therapeutics|October 1, 1993
High-density lipoprotein cholesterol elevation with gemfibrozil: effects of baseline level and modifying factorsM Mänttäri, L Tenkanen, H Mäenpää, et al.Cancer Causes & Control : CCC|November 15, 2000
Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)M H Ahonen, L Tenkanen, L Teppo, et al.Hypertension (Dallas, Tex. : 1979)|January 1, 1995
Antihypertensive therapy in dyslipidemic men. Effects on coronary heart disease incidence and total mortalityM Mänttäri, L Tenkanen, V Manninen, et al.Atherosclerosis|March 1, 1991
Lifestyle determinants of HDL2- and HDL3-cholesterol levels in a hypercholesterolemic male populationM Mänttäri, P Koskinen, V Manninen, et al.American Heart Journal|March 29, 2001
Joint effects of C-reactive protein and other risk factors on acute coronary eventsH Kervinen, T Palosuo, V Manninen, et al.The American Journal of Cardiology|May 2, 1989
Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart StudyV Manninen, J K Huttunen, O P Heinonen, et al.Circulation|January 1, 1995
Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged menO Vaarala, M Mänttäri, V Manninen, et al.Clinical and Experimental Rheumatology|September 1, 1996
Antibodies binding to anionic phospholipids but not to oxidized low-density lipoprotein are associated with thrombosis in patients with systemic lupus erythematosusK Aho, O Vaarala, L Tenkanen, et al.Drugs|January 1, 1990
HDL-cholesterol as a risk factor in coronary heart disease. An update of the Helsinki Heart StudyM H Frick, V Manninen, J K Huttunen, et al.Atherosclerosis|February 1, 1994
Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart StudyA Hautanen, M Mänttäri, V Manninen, et al.Pageof 4